Evidence map›Paper›PMID 31993396›Full record

ArticleIranian journal of public health2019

SCC

Yasaman Jamshidi, Mohammad Reza Pourmand, Zahra Pakbaz, Amirhossein Pourmand, Abbas Rahimi Foroushani, Mohammad Ali Sahraian

Open access · goldAbstract read
In one paragraph

Article in Iranian journal of public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yasaman JamshidiDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Reza PourmandDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Zahra PakbazDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Amirhossein PourmandUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Abbas Rahimi ForoushaniDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali SahraianMS Research Center, Neuroscience Institute, Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRSina Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsymptomatic nasal colonization of Methicillin-Resistant

methodsA cross-sectional descriptive study was conducted from Feb and Jun 2017 in MS Research Center, Tehran University of Medical Sciences (TUMS), Iran. Overall, 620 nasal swabs were collected (325 from MS patients and 295 from control group). Antimicrobial susceptibility test was performed using the disk diffusion and E-test method. Presence of

resultsThe frequency of MRSA among the MS patients and control group was almost equal (9.2% and 10.1%, respectively). SCC

conclusionAlthough most MRSA isolates were collected from inpatients, interestingly there is a high frequency of SCC

Indexed as

Methicillin-resistant Staphylococcus aureusMultiple sclerosisSCCmec typing

Identifiers

PMID31993396
PMCPMC6974861
OpenAlexW2996467893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.